Natriumklorid Baxter Viaflo 9 mg/ ml Norge - norsk - Statens legemiddelverk

natriumklorid baxter viaflo 9 mg/ ml

baxter medical ab - natriumklorid - infusjonsvæske, oppløsning - 9 mg/ ml

Natriumklorid-Glucos Baxter Viaflo 4.5 mg/ ml / 25 mg/ ml Norge - norsk - Statens legemiddelverk

natriumklorid-glucos baxter viaflo 4.5 mg/ ml / 25 mg/ ml

baxter medical ab - natriumklorid / glukosemonohydrat - infusjonsvæske, oppløsning - 4.5 mg/ ml / 25 mg/ ml

Natriumklorid-Glucos Baxter Viaflo 9 mg/ ml / 50 mg/ ml Norge - norsk - Statens legemiddelverk

natriumklorid-glucos baxter viaflo 9 mg/ ml / 50 mg/ ml

baxter as - natriumklorid / glukose - infusjonsvæske, oppløsning - 9 mg/ ml / 50 mg/ ml

Ringer-Acetat Baxter Viaflo Norge - norsk - Statens legemiddelverk

ringer-acetat baxter viaflo

baxter medical ab - natriumklorid / kaliumklorid / kalsiumkloriddihydrat / magnesiumkloridheksahydrat / natriumacetattrihydrat - infusjonsvæske, oppløsning - 5.86 g/ l / 0.3 g/ l / 0.29 g/ l / 0.2 g/ l / 4.08 g/ l

Sevofluran Baxter 100 % v/v Norge - norsk - Statens legemiddelverk

sevofluran baxter 100 % v/v

baxter medical ab - sevofluran - væske til inhalasjonsdamp - 100 % v/v

Sterilt vann Baxter Viaflo - Norge - norsk - Statens legemiddelverk

sterilt vann baxter viaflo -

baxter medical ab - vann til injeksjonsvæsker - oppløsningsvæske til parenteral bruk

Profast 10 mg/ ml Norge - norsk - Statens legemiddelverk

profast 10 mg/ ml

baxter b.v. - propofol - injeksjons-/infusjonsvæske, emulsjon - 10 mg/ ml

Profast 20 mg/ ml Norge - norsk - Statens legemiddelverk

profast 20 mg/ ml

baxter b.v. - propofol - injeksjons-/infusjonsvæske, emulsjon - 20 mg/ ml

Celdoxome pegylated liposomal Den europeiske union - norsk - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doxorubicin hydroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiske midler - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Plasmalyte Glucos Norge - norsk - Statens legemiddelverk

plasmalyte glucos

baxter medical ab - glukosemonohydrat / natriumklorid / kaliumklorid / magnesiumkloridheksahydrat / natriumacetattrihydrat / natriumglukonat - infusjonsvæske, oppløsning - 50 mg/ ml / 5.26 mg/ ml / 0.37 mg/ ml / 0.3 mg/ ml / 3.68 mg/ ml / 5.02 mg/ ml